Skip to Content
Duotrope®

James Gunn's Ad Astra 31

Recent cover image or website screenshot for James Gunn's Ad Astra © James Gunn's Ad Astra

Go to publication's website

Report:
Submission/Response
Correction/Update
New Cover Art

Request (Editors only):
Interview
Duosuma Submission Manager

Support this Publisher:
Make a Donation

About

James Gunn’s Ad Astra combines the best parts of creative magazines and scholarly journals and brings them to Web. This site will showcase the imaginations of creators and fans, and will show the research and study of scholars inspired by speculative fiction. Our initial publication launched in June of 2012. All submissions will be reviewed by volunteer readers and editors. All research articles will be reviewed by peers. We are a volunteer organization inspired by the Gunn-era Center for the Study of Science Fiction, the legacy of which continues with the new Ad Astra Center for Science Fiction & the Speculative Imagination.

Peer Review: This publication uses peer review for some or all submissions. Check for details.

Country of Publication

United States

Publication Medium & Frequency

Electronic Publication Electronic PublicationPublished 2 x per year.

Fiction Open
Audience:

Open to a broad Audience.

Genres:
GenreSubgenres
Science Fiction Science FictionOpen to all/most Subgenres.
Lengths:
Short Story Short Story1,000 - 7,500 words.
Styles:

Open to all/most Styles, including: Mainstream.

Topics:

Open to all/most Topics.

Payment:

Token payment (under 1 US cent per word) to Semi-pro payment (1-4.9 US cents per word) Pay ranges from Token payment (under 1 US cent per word) to Semi-pro payment (1-4.9 US cents per word).
Note: We list broad pay categories rather than prize specifics. Check with the publisher for details.

Submissions:

Method: Electronic submissions.
Reprints: Reprints are NOT allowed.
Simultaneous submissions: Simultaneous submissions are NOT allowed.
Media: Text.

Nonfiction Temp Closed
Audience:

Open to a broad Audience.

Lengths:
Article ArticleUp to 7,500 words.
Styles:

Academic.

Topics:

Literature/Books (Theory/Analysis/Criticism, See guidelines).

Payment:

Unknown payment Unknown payment.
Note: We list broad pay categories rather than prize specifics. Check with the publisher for details.

Submissions:

Method: Electronic submissions.
Reprints: Reprints are NOT allowed.
Simultaneous submissions: Simultaneous submissions are NOT allowed.
Media: Text.

Poetry Open
Audience:

Open to a broad Audience.

Genres:
GenreSubgenres
Science Fiction Science FictionOpen to all/most Subgenres.
Lengths:
Poem PoemNo line limits known; Up to 3 pieces.
Poetry Forms:

Open to all/most Forms.

Styles:

Open to all/most Styles, including: Mainstream.

Topics:

Open to all/most Topics.

Payment:

Semi-pro payment (US$5-49 per poem) Semi-pro payment (US$5-49 per poem).
Note: We list broad pay categories rather than prize specifics. Check with the publisher for details.

Submissions:

Method: Electronic submissions.
Reprints: Reprints are NOT allowed.
Simultaneous submissions: Simultaneous submissions are NOT allowed.
Media: Text.

Always check guidelines for details and restrictions. If you aren't familiar with these terms, see our glossary.

James Gunn's Ad Astra Submission Statistics — Free Preview!

The statistics in this section are compiled from submission reports sent to us through our submission tracker. They are not provided by the publication's editors/staff or by Duotrope's admins. Information in this section is updated a few times per day. Learn more about the statistics.
AccuracyWe have received 16 reports from 13 different members within the past 12 months, not including pending responses (see below). The more responses reported, the more accurate the information.
Days Reported55 min | 155.6 mean avg | 118.5 median | 366 max days (100.1 std dev)
Responses75.00 %
Acceptances6.25 % of submissions accepted (312.0 avg. days per acceptance) | 7.69 % of submitters accepted Rejections are often underreported, which skews the statistics in favor of acceptances. Most publishers have a lower acceptance rate than indicated here.
Rejections68.75 % (101.0 avg. days per rejection) | 0.0 % personal, 72.7 % form, 27.3 % unspecified | 6.3 % rewrite requests
Non-Responses25.00 %
Lost/Returned-
Never Responded12.50 % (364.5 avg. days before reporting submissions as never responded)
Withdrawals12.50 % (169.0 avg. days per withdrawal)
Pending8 responses are pending (3 min | 125.3 mean avg | 134.5 median | 291 max days waiting | 109.0 std dev) from 8 different members This only includes pending reports from users who have been active on Duotrope within the past 30 days

Other Information

Most submissions are acknowledged on the same day.
Most recent response reported was received on 13 Apr 2024.
Responses have been received for submissions sent as recently as 29 Dec 2023.

Work submitted here was also submitted to...

This section is available to subscribers only. Sign up and start your free trial today!

Members accepted here also had work accepted by...

This section is available to subscribers only. Become a member and start your free trial today!

Your Submissions

This section is available to subscribers only. Join today!

Dates

Last Updated: 27 Dec 2023
Last Audited: 27 Dec 2023. (We audit each active listing twice a year. Learn more at link.)
Date Added: 14 Dec 2011

Before Submitting

We cannot guarantee that the information on this page is correct. It is not unusual for publications to evolve or close without notice. We do our best to keep up, but it isn't always possible. Duotrope listings do not imply endorsement or recommendation of the project being listed. Before submitting, you should use your own judgment to determine whether the project meets your standards.

  • Always read the full guidelines provided by the publisher.
  • Try to read at least one previous publication to get a better idea of what the editor would like to see.
  • Unless the publisher's guidelines state otherwise, always use industry standard manuscript formatting.
  • Be professional, patient, and persistent.